Medical management of failed back surgery syndrome in Europe: Evaluation modalities and treatment proposals

被引:23
作者
Durand, G. [1 ]
Girodon, J. [1 ]
Debiais, F. [1 ]
机构
[1] CHU Poitiers, Serv Rhumatol, F-86021 Poitiers, France
关键词
Failed back surgery syndrome; Postoperative sciatica; Medical management; EPIDURAL STEROID INJECTION; NEUROPATHIC PAIN; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENT; GABAPENTIN; EFFICACY; MORPHINE; PLACEBO; COMBINATION; QUESTIONNAIRE;
D O I
10.1016/j.neuchi.2015.01.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Failed back surgery syndrome (FBSS) is defined as persistent pain more than 3 months after any form of spinal surgery. Due to its multifactorial origin, FBSS is often difficult to treat. In this context of failed back surgery, a very thorough assessment must be conducted concerning the site and characteristics of the pain (nociceptive or neuropathic), its mode of onset (presence or absence of pain-free intervals), and its impact on the patient's work and social life. Physical examination must exclude a non-spinal cause for the pain. MRI is the imaging modality of choice in this disease, but is often difficult to interpret, as MR signals are modified for 6 months after the operation. Scar tissue, which can be distinguished from recurrent disc hernia by its gadolinium enhancement, is present even in asymptomatic patients. After having eliminated infection and sacroiliac or posterior facet joint disease, the main aetiologies investigated are foraminal stenosis, degenerative disc disease, recurrent disc hernia, and non-union of spinal fusion: sometimes patients only experience persistent neuropathic pain. The treatment of failed back surgery syndrome with a predominant neuropathic component is based on the use of analgesics, especially antiepileptics, antidepressants or transcutaneous electrical stimulation. Epidural spinal infiltration should be considered as second-line treatment in view of the risk of serious neurological complications. Management must be based on a global, multidisciplinary approach with identification of any cognitive or behavioural disorders in combination with an appropriate functional rehabilitation programme. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S57 / S65
页数:9
相关论文
共 59 条
  • [1] AFSSAPS, 2011, RISQ PAR TETR LIE IN
  • [2] [Anonymous], 1994, CLASSIFICATION CHRON
  • [3] [Anonymous], 2010, Douleurs: Evaluation-Diagnostic-Traitement, DOI DOI 10.1016/J.D0ULER.2009.12.009
  • [4] [Anonymous], 2011, COCHRANE DATABASE SY
  • [5] [Anonymous], COCHRANE DATABASE SY
  • [6] [Anonymous], COCHRANE DATABASE SY
  • [7] EFNS guidelines on pharmacological treatment of neuropathic pain
    Attal, N.
    Cruccu, G.
    Haanpaa, M.
    Hansson, P.
    Jensen, T. S.
    Nurmikko, T.
    Sampaio, C.
    Sindrup, S.
    Wiffen, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (11) : 1153 - 1169
  • [8] The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy
    Baron, Ralf
    Freynhagen, Rainer
    Toelle, Thomas R.
    Cloutier, Christian
    Leon, Teresa
    Murphy, T. Kevin
    Phillips, Kern
    [J]. PAIN, 2010, 150 (03) : 420 - 427
  • [9] The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research
    Bennett, MI
    Smith, BH
    Torrance, N
    Potter, J
    [J]. JOURNAL OF PAIN, 2005, 6 (03) : 149 - 158
  • [10] Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)
    Bouhassira, D
    Attal, N
    Alchaar, H
    Boureau, F
    Brochet, B
    Bruxelle, J
    Cunin, G
    Fermanian, J
    Ginies, P
    Grun-Overdyking, A
    Jafari-Schluep, H
    Lantéri-Minet, M
    Laurent, B
    Mick, G
    Serrie, A
    Valade, D
    Vicaut, E
    [J]. PAIN, 2005, 114 (1-2) : 29 - 36